Post-operative day | |||||||
---|---|---|---|---|---|---|---|
6 | 9 | 10 | 11 | 14 | 131 | 233 | |
Time from last administration of edoxaban tablet to blood collection (h) | - | 24 | 8 | 24 | 96 | 26 | 2 |
Plasma concentration of edoxaban (ng/mL) | - | 131.1 | 796.2 | 116.1 | < 5.0 | < 5.0 | 413.2 |
Plasma concentration of M-4 (ng/mL) | - | 115.8 | 878.5 | 216.2 | 2.1 | < 2.0 | 189.7 |
M-4 ratio (%) | - | 88.3 | 110.3 | 186.2 | - | - | 45.9 |
Plasma concentration of coproporphyrin-I (ng/mL) | 2.4 | 4.6 | 7.4 | 6.0 | 0.8 | 0.6 | 1.0 |
Plasma concentration of valsartan (µg/mL) | 2.4 | 5.7 | 9.4 | 10.4 | 1.4 | 1.0 | -b |
Plasma concentration of IL-6 (pg/mL) | 18.0 | 20.1 | 76.0 | 23.6 | 7.2 | 5.2 | < 3.1 |
Serum C-reactive protein (mg/L) | 66.4 | 50.5 | 64.2 | 147.1 | 17.4 | 6.0 | 14.0 |
Serum creatinine (mg/dL) | 0.88 | 1.20 | 2.21 | 2.32 | 0.96 | 0.89 | 0.89 |
Creatinine clearancea (mL/min) | 62.5 | 46.3 | 25.1 | 23.9 | 57.8 | 59.0 | 62.4 |
Body weight (kg) | 55.5 | - | - | - | - | 52.5 | 58.0 |